Illumina, Inc. (LON:0J8Z)

Market Cap	13.03B -23.5%
Revenue (ttm)	3.22B -0.7%
Net Income	630.31M
EPS	4.04
Shares Out	n/a
PE Ratio	20.68
Forward PE	22.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190
Average Volume	931
Open	116.69
Previous Close	116.96
Day's Range	112.81 - 118.45
52-Week Range	68.69 - 155.12
Beta	1.45
RSI	25.81
Earnings Date	Feb 5, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1998
• Employees: 9,030
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8Z

Financial Performance

Financial numbers in USD